For the quarter ending 2026-03-31, SENS had -$10,622K decrease in cash & cash equivalents over the period. -$32,136K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -32,333 | -20,823 | -19,530 | -28,760 |
| Depreciation and amortization expense | 545 | 382 | 376 | 754 |
| Non-cash interest expense (debt discount and deferred costs) | 325 | 321 | 285 | 787 |
| Net amortization of premiums and accretion of discounts on marketable securities | 198 | 358 | 590 | 473 |
| Stock-based compensation expense | 2,276 | 2,625 | 2,795 | 4,733 |
| Provision for inventory obsolescence and losses | -345 | 469 | 71 | 154 |
| Allowance for credit losses | 420 | 931 | - | - |
| Other | -727 | - | 251 | 480 |
| Accounts receivable | 3,010 | 5,126 | 2,289 | -650 |
| Prepaid expenses and other current assets | -252 | -2,123 | 1,499 | -829 |
| Inventory | 1,346 | 848 | 1,681 | 446 |
| Deposits and other assets | 301 | 0 | 0 | -13 |
| Accounts payable | -870 | -1,824 | 3,613 | -571 |
| Accrued expenses and other liabilities | 3,004 | 5,121 | 2,618 | -2,532 |
| Accrued interest | -62 | 11 | 0 | -501 |
| Payments on lease liabilities | -386 | -238 | -237 | -464 |
| Net cash used in operating activities | -32,025 | -17,965 | -15,817 | -25,347 |
| Capital expenditures | 111 | 394 | 164 | 558 |
| Purchase of marketable securities | 4,042 | 0 | 6,295 | 94,398 |
| Proceeds from sale and maturity of marketable securities | 23,260 | 23,037 | 25,350 | - |
| Cash paid in connection with asset acquisition | 1,111 | - | - | - |
| Net cash provided by (used in) investing activities | 17,996 | 22,643 | 18,891 | -94,956 |
| Proceeds from issuance of common stock, net-Equity Distribution Agreement | - | 1,661 | 204 | 26,456 |
| Repayment of 2025 notes | - | 0 | 0 | 20,399 |
| Proceeds from issuance of common stock, net-Offering | - | 0 | 0 | 52,122 |
| Proceeds from issuance of common stock, net-Private Placement | - | 0 | 0 | 20,148 |
| Proceeds from issuance of common stock, net | 3,493 | - | - | - |
| Proceeds from exercise of stock options, rsus and espp issuances, net | 64 | 0 | 74 | 69 |
| Payment of debt modification costs | - | 0 | 412 | - |
| Taxes paid related to net share settlement of equity awards | 150 | 563 | 0 | 1,172 |
| Net cash provided by financing activities | 3,407 | 1,098 | -134 | 77,224 |
| Net decrease in cash and cash equivalents | -10,622 | 5,776 | 2,940 | -43,079 |
| Cash and cash equivalents and restricted cash, at beginning of period | 40,549 | 74,912 | 74,912 | - |
| Cash and cash equivalents and restricted cash, at ending of period | 29,927 | 5,776 | 34,773 | - |
Senseonics Holdings, Inc. (SENS)
Senseonics Holdings, Inc. (SENS)